Segment Information (Tables)

12 Months Ended

Mar. 31, 2023

Segment Reporting [Abstract]

Schedule Of Company Revenue and Adjusted EBITDA by Segment

The Company’s revenue and Adjusted EBITDA by segment is as follows:

	Year Ended March 31,
	2023			2022			2021
	(in thousands)
Segment Revenue:
Consumer and Research Services	$	299,489		$	271,893		$	243,866
Therapeutics		-			-			54
Total revenue	$	299,489		$	271,893		$	243,920
Segment Adjusted EBITDA:
Consumer and Research Services Adjusted EBITDA	$	(17,997	)	$	(30,112	)	$	12,796
Therapeutics Adjusted EBITDA		(88,503	)		(76,944	)		(58,734	)
Unallocated Corporate (1)		(54,801	)		(43,684	)		(30,587	)
Total Adjusted EBITDA	$	(161,301	)	$	(150,740	)	$	(76,525	)
Reconciliation of net loss to Adjusted EBITDA:
Net loss	$	(311,656	)	$	(217,490	)	$	(183,619	)
Adjustments
Interest income, net		(9,676	)		(277	)		(255	)
Other (income) expense, net		93			83			(1,322	)
Change in fair value of warrant liabilities		—			(32,989	)		—
Income tax benefit		(2,772	)		(3,480	)		—
Depreciation and amortization		20,239			18,899			20,246
Amortization of acquired intangible assets		16,486			7,269			—
Impairment of acquired intangible asset		9,968			—			—
Stock-based compensation expense		116,017			57,933			88,425
Acquisition-related costs (2)		—			9,362			—
Litigation settlement (3)		—			9,950			—
Total Adjusted EBITDA	$	(161,301	)	$	(150,740	)	$	(76,525	)

(1)Certain expenses such as Finance, Legal, Regulatory and Supplier Quality, Corporate Communications, and CEO Office are not reported as part of the reporting segments as reviewed by the CODM. These amounts are included in Unallocated Corporate.

(2)For the fiscal year ended March 31, 2022, acquisition-related costs primarily consisted of advisory, legal and consulting fees.

(3)For the fiscal year ended March 31, 2022, litigation settlement is litigation cost net of insurance recoveries, which is not expected to occur on a recurring basis and not part of the Company's normal and continued business activity.

Summary of Customers Accounting for 10% or More of Segment Revenues

Customers accounting for 10% or more of segment revenues were as follows:

	Year Ended March 31,
	2023				2022				2021
	(in thousands, except percentages)
Consumer and Research Services Segment Revenue:
Customer C (1)	$	65,721	22	%	$	53,875	20	%	$	51,786	21	%
Customer B (2)	$	47,448	16	%	$	46,064	17	%	$	39,917	16	%

(1)Customer C revenues are primarily in the United States.

(2)Customer B revenues are in the U.K.